Israeli Study Finds Fourth COVID-19 Dose Insufficient Against Omicron
An Israeli study is the first to administer 4 COVID-19 shots, but the boosted antibodies may still not be enough to prevent Omicron breakthrough infections.
Removing a Viral Protein Allows the Immune System to Destroy Respiratory Viruses
Eliminating the NS2 viral protein of Respiratory Syncytial Virus (RSV) helps the body to destroy the virus before it causes severe inflammation.
E-Cigarette Users at Higher Risk for Symptomatic COVID-19
People who vape with e-cigarettes and contract COVID-19 are significantly more likely to experience symptoms.
COVID-19 or the Flu? Identifying Similarities and Differences
Key signs and symptoms to help distinguish between the 2 respiratory illnesses.
RSV in Children with Influenza-Like Illness
A team of researchers sought to study the epidemiological characteristics of RSV in pediatric influenza-like illness cases.
Unvaccinated Pregnant People With COVID-19 Have Increased Risk of Poor Birth Outcomes
Even if they did not experience severe symptoms, unvaccinated people who contract COVID-19 while pregnant are more likely to have poor birth outcomes.
1 in 10 People May Still Have Infectious COVID-19 After 10 Days
Over 1 in 10 people may harbor infectious and transmissible COVID-19 virus after the recommended 10-day quarantine period.
Usual Source of Care and Flu Vaccination Rates in Pregnant Women
A new study sought to address the association between a usual source of care and influenza vaccination rates among pregnant women.
COVID-19 Outcome Severity in Children
A study of children positive for COVID-19 found the overall risk of developing severe disease to be low, but risk factors included age, underlying chronic illness, and symptom duration.
A Booster mRNA Vaccine Required to Protect Against Omicron Variant
New data suggests an additional “booster” dose of an mRNA COVID-19 vaccine is no longer just recommended but required for protection against the infectious Omicron variant.
Lower BMI Increased Risk of C Diff Infection in Elderly Pneumonia Patients
Underweight elderly pneumonia patients were more likely to contract C difficile infection.
Successful Weight-Loss Surgery Reduces Risk of Severe COVID-19
COVID-19 patients who underwent prior weight-loss surgery were significantly less likely to experience severe disease outcomes.
US Surpasses 500,000 Daily New COVID-19 Cases
The US is on track to reach new records for 7-day average cases, though death rates remain lower.
FDA Grants Emergency Authorization to COVID-19 Pill Molnupiravir
The oral antiviral therapy proceeds the first indication for the drug class by just a day; the US will now have multiple pills to treat COVID-19.
Your Seat on Public Transportation Determines Exposure to Infectious Droplets
Here’s where you should sit on the bus to avoid COVID-19 droplets.
Omicron is Now the Dominant Variant in the US, Accounts for 73% of All New Cases
Less than 3 weeks after it was first reported, Omicron becomes the dominant COVID-19 variant in the US.
Estimating Respiratory Syncytial Virus Resurgence After the COVID-19 Pandemic
Respiratory syncytial virus (RSV) cases decreased due to COVID-19 precautions. Investigators estimated the rate and timing of RSV resurgence over the next few years.
Moderna COVID-19 Vaccine Boosters May Provide Significant Omicron Antibodies
Two different doses of the company's mRNA vaccine were found to increase antibodies by up to 83-fold.
Respiratory Virus Season: Colds and COVID-19 Update
Will this winter bring the feared twindemic of SARS-CoV-2 and influenza, or will another common infection reemerge?
Is There a Better Choice Than TMP-SMX to Treat Stenotrophomonas maltophilia Infections?
COVID-19: Year 2 in Review
A reflection on the wins and setbacks in the second year of our pandemic, 2021.
CDC Influenza Surveillance Weekly Report
Clinical and public health laboratories reported increased influenza virus detections over the past few weeks, but US cases remains comparatively low to previous flu seasons.
Lower-Dose, Shorter-Duration of Amoxicillin Noninferior for Treating CAP in Children
Lower-dose amoxicillin was noninferior to higher doses for treating children diagnosed with community-acquired pneumonia, according to a new study that also showed that shorter treatment duration was noninferior to longer treatment duration.
Public Health Watch: 2020 Flu Vaccine Uptake Shows Some Public Health Messaging Takes Hold
Analysis documents 9% rise in shots distributed after federal officials pushed for vaccination.
Seqirus Granted FDA Approval for First Cell-Based Influenza Vaccine
The FDA has approved patients 6 months and older to receive Seqirus's first-ever adjuvanted, cell-based influenza vaccine.
Using Lessons Learned from COVID-19 to Prepare for the Next Influenza Pandemic
The National Academy of Medicine released 4 reports with COVID-19-influenced recommendations to prepare and respond to an influenza pandemic.
Pfizer COVID-19 Antiviral Pill Significantly Reduces Hospitalizations, Death
Interim, unpublished data show PAXLOVID is associated with 89% reductions in risk of COVID-19 hospitalization or death. Pfizer is now seeking FDA emergency authorization.
US Private Employer COVID-19 Vaccine Mandates Will Begin January 4
The Biden administration is also setting mandates for health care workers in facilities receiving federal aid.
Molnupiravir Becomes First Globally Authorized COVID-19 Pill
The investigational oral antiviral therapy from Merck is still awaiting FDA authorization.
Better Homes & Gardens Aromatherapy Spray Causes Melioidosis Outbreak
The Walmart-distributed Better Homes & Gardens aromatherapy spray “Lavender & Chamomile with Gemstones” was identified as causing melioidosis in 4 individuals, 2 of whom died.
2 Clarke Drive Cranbury, NJ 08512